Search results
Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018.
Since becoming CEO of Novartis in 2018, Vas has led a strategic and cultural transformation to build a fully focused medicines company—one that delivers high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.
Chairperson of the Board. African Parks takes on the complete responsibility for the rehabilitation and long-term management of national parks in partnership with governments and...
- Novartis
Apr 12, 2024 · Over the past seven years, Vasant ‘Vas’ Narasimhan has led the transformation of Novartis into a focussed medicines company rebuilt on the bedrock of R&D and innovation.
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations.
Apr 15, 2024 · Vasant Narasimhan, CEO, Novartis Image: Mexy Xavier. I n the world of big pharma, Vasant ‘Vas’ Narasimhan is most certainly an exception. The son of Indian immigrants and a doctor by...
Dr. Vas Narasimhan is CEO of Novartis, one of the world’s most innovative medicines companies, since 2018. During his career at Novartis, he has overseen the licensure of more than 30 novel...
Mar 18, 2020 · Vas Narasimhan is one of the youngest leaders of a major global company. While you might think that putting someone relatively young in charge of a global firm is a bit unusual...
Vas Narasimhan: the American trying to reshape Novartis. The Swiss company’s chief executive has to decide on the future of its $10bn generics business. Vas Narasimhan, who trained as a doctor at...
Apr 17, 2024 · Narasimhan, who was recently in Hyderabad at the company’s global capability centre, has hived off subsidiaries to focus entirely on pure-play innovative medicines, and has announced plans to...
